Is Charles River Laboratories International Inc (NYSE: CRL) Still On The Rise?

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.

Stocks Info

This NYSE-listed company operates within the Diagnostics & Research industry segment, falling under the Healthcare sector. The current market capitalization of Charles River Laboratories International Inc is $6.66B. A total of 1.3 million shares were traded on the day, compared to an average of 1.78M shares.

In the most recent transaction, MASSARO GEORGE sold 140 shares of CRL for 137.57 per share on May 15 ’25. After the transaction, the Director now owns 5,575 company shares. In a previous transaction on May 14 ’25, MASSARO GEORGE sold 140 shares at 140.73 per share. CRL shares that Director owns now total 5,715.

Among the insiders who sold shares, LaPlume Joseph W disposed of 500 shares on May 13 ’25 at a per-share price of $145.41. This resulted in the EVP, Corp Strategy & Develop holding 19,513 shares of CRL after the transaction. In another insider transaction, MASSARO GEORGE bought 280 shares at $140.73 per share on May 14 ’25.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, CRL has a high of $254.15 and a low of $91.86.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. CRL’s latest balance sheet shows that the firm has $241.21M in Cash & Short Term Investments as of fiscal 2021. There were $2.92B in debt and $1.03B in liabilities at the time. Its Book Value Per Share was $65.04, while its Total Shareholder’s Equity was $2.59B.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CRL is Buy with a score of 3.40.

Most Popular

Related Posts